Roche (RHHBY) Acquires MTM Laboratories AG for Up to $260 Million
7/19/2011 6:20:53 AM
More...
|
MTM Laboratories AG’s p16/Ki-67 Dual Immuno-Staining Identifies High-Grade Cervical Disease in ASC-US and LSIL with High Sensitivity and Specificity
3/30/2011 10:24:54 AM
More...
|
MTM Laboratories AG Extends Series C Financing Round by EUR 7 Million ($9.7 Million)
11/8/2010 6:20:24 AM
More...
|
MTM Laboratories AG's Cintec(R) PLUS, P16/Ki-67 Dual Staining Kit, Delivers New Solution To Manage Pap Negative But HPV Positive Women
5/27/2010 11:16:05 AM
More...
|
MTM Laboratories AG Announces That 68 Abstracts Will Be Presented At USCAP Detailing The Utility Of P16 Across Multiple Clinical Applications
3/18/2010 3:56:45 PM
More...
|
MTM Laboratories AG's Cintec(R) P16 Histology Test Increases Accuracy In Diagnosing High Grade Cervical Lesions
2/16/2010 1:35:29 PM
More...
|
MTM Laboratories AG to Present at Biotechnology Industry Organization (BIO)-Europe 2009 in Vienna/Austria
10/27/2009 2:46:47 PM
More...
|
MTM Laboratories AG Extends Series C Financing Round by EUR 7 Million Bringing Total to EUR 39 Million (USD 57 Million)
10/5/2009 11:27:16 AM
More...
|
MTM Laboratories AG to Present at BIO-Europe 2008 in Mannheim/Heidelberg
11/13/2008 3:14:10 PM
More...
|
MTM Laboratories AG Launches CINtec(R) Cytology Kit in Europe with Extended Clinical Claims for Cervical Cancer Diagnosis
9/17/2008 7:01:18 AM
More...
|
|